NURCHI, VALERIA MARINA
 Distribuzione geografica
Continente #
EU - Europa 247.346
NA - Nord America 18.718
AS - Asia 6.629
SA - Sud America 1.084
Continente sconosciuto - Info sul continente non disponibili 580
AF - Africa 187
OC - Oceania 30
Totale 274.574
Nazione #
IT - Italia 240.322
US - Stati Uniti d'America 18.341
NL - Olanda 2.978
SG - Singapore 2.486
CN - Cina 2.305
UA - Ucraina 1.152
BR - Brasile 854
SE - Svezia 809
VN - Vietnam 530
DE - Germania 522
FI - Finlandia 444
GB - Regno Unito 379
FR - Francia 332
CA - Canada 217
HK - Hong Kong 204
IN - India 196
KR - Corea 170
BD - Bangladesh 155
RU - Federazione Russa 91
TR - Turchia 74
IQ - Iraq 73
AR - Argentina 67
MX - Messico 67
JP - Giappone 55
ES - Italia 54
IR - Iran 54
PL - Polonia 52
ZA - Sudafrica 52
ID - Indonesia 42
EC - Ecuador 40
PK - Pakistan 39
UZ - Uzbekistan 35
AT - Austria 30
CO - Colombia 29
MY - Malesia 29
AU - Australia 28
BE - Belgio 28
VE - Venezuela 27
JM - Giamaica 24
EG - Egitto 23
PH - Filippine 23
IE - Irlanda 22
MA - Marocco 22
CR - Costa Rica 21
CL - Cile 20
TN - Tunisia 20
CH - Svizzera 19
IL - Israele 19
TH - Thailandia 18
UY - Uruguay 18
SA - Arabia Saudita 17
KE - Kenya 15
GR - Grecia 14
PE - Perù 13
DZ - Algeria 11
JO - Giordania 11
LY - Libia 11
SY - Repubblica araba siriana 11
AM - Armenia 10
CZ - Repubblica Ceca 10
RO - Romania 9
AL - Albania 8
AZ - Azerbaigian 8
BG - Bulgaria 8
GT - Guatemala 8
PY - Paraguay 8
RS - Serbia 8
SC - Seychelles 8
TT - Trinidad e Tobago 8
TW - Taiwan 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
DK - Danimarca 7
EE - Estonia 7
LB - Libano 7
NP - Nepal 7
KZ - Kazakistan 6
LT - Lituania 6
PT - Portogallo 6
SK - Slovacchia (Repubblica Slovacca) 6
BY - Bielorussia 5
ET - Etiopia 5
HN - Honduras 5
HU - Ungheria 5
MD - Moldavia 5
NG - Nigeria 5
PS - Palestinian Territory 5
BS - Bahamas 4
CI - Costa d'Avorio 4
EU - Europa 4
LK - Sri Lanka 4
NI - Nicaragua 4
SN - Senegal 4
BB - Barbados 3
BH - Bahrain 3
GD - Grenada 3
KG - Kirghizistan 3
MN - Mongolia 3
PA - Panama 3
PR - Porto Rico 3
Totale 273.961
Città #
Cagliari 235.431
Uta 3.910
Amsterdam 2.944
Ashburn 2.222
Fairfield 1.696
Woodbridge 1.283
Singapore 1.124
San Jose 1.113
Houston 889
Chandler 832
Dallas 751
Wilmington 697
Ann Arbor 688
Boardman 685
Seattle 641
Jacksonville 622
Cambridge 588
Nyköping 573
Beijing 419
Dearborn 338
Council Bluffs 313
Los Angeles 285
Helsinki 260
Santa Clara 229
Nanjing 195
The Dalles 194
Boston 191
Lauterbourg 190
Hong Kong 175
Ho Chi Minh City 164
Hefei 161
New York 155
Seoul 153
Hanoi 127
Buffalo 126
Shanghai 123
São Paulo 107
San Diego 99
Escalaplano 79
Guangzhou 73
Nanchang 72
Chicago 70
Milan 70
Redwood City 70
Toronto 69
Shenyang 61
Dong Ket 60
Atlanta 59
Hebei 57
London 54
Orem 53
Mountain View 51
Tianjin 51
Changsha 49
Rome 49
Columbus 47
Redondo Beach 46
Chennai 41
Princeton 41
Verona 40
Jiaxing 39
Brooklyn 38
Baghdad 35
Frankfurt am Main 35
Norwalk 35
Ottawa 34
Phoenix 34
Tokyo 33
Sassari 32
Tashkent 32
Zhengzhou 32
Rio de Janeiro 30
Da Nang 27
Washington 27
Jinan 26
Montreal 26
North Bergen 26
Orange 26
Brussels 25
Warsaw 25
Nuremberg 24
San Francisco 24
Dhaka 23
Hangzhou 23
Las Vegas 23
Pune 22
Charlotte 20
Denver 20
Naples 19
Auburn Hills 18
Haiphong 18
Ningbo 18
Brasília 17
Dublin 17
Istanbul 17
Johannesburg 17
Paris 17
Wuhan 17
Manchester 16
Pars 16
Totale 262.958
Nome #
Iron Chelation for Iron Overload in Thalassemia 5.773
A new bis-3-hydroxy-4-pyrone as a potential therapeutic iron chelating agent. Effect of connecting and side chains on the complex structures and metal ion selectivity 3.872
Hydroxypyridinones with enhanced iron chelating properties. Synthesis, characterization and in vivo tests of 5-hydroxy-2-(hydroxymethyl)pyridine-4(1H)-one 3.648
Complex formation equilibria of Cu2 + and Zn2 + with Irbesartan and Losartan 3.564
para-Aminosalicylic acid in the treatment of manganese toxicity. Complexation of Mn2+ with 4-amino-2-hydroxybenzoic acid and its N-acetylated metabolite 3.562
Multiple Sclerosis and environmental factors. 3.325
Gold - Old drug with new potentials 3.240
Simple solid-phase spectrophotometric method for free iron(III) determination 3.097
Metal coordination and tyrosinase inhibition studies with Kojic-βAla-Kojic 2.983
Sampling variability in hepatic iron concentration in beta-thalassemia 2.881
Searching for new aluminium chelating agents: a family of hydroxypyrone ligands 2.813
Salicylamide derivatives for iron and aluminium sequestration. From synthesis to complexation studies 2.761
The essential metals for humans: a brief overview 2.718
Assessment, validation and application to real samples of an RP-HPLC method for the determination of Guayulins A, B, C and D in Guayule Shrub 2.670
Looking at new ligands for chelation therapy 2.574
Sorption of ofloxacin and chrysodine by grape stalk. A representative case of biomass removal of emerging pollutants from wastewater 2.553
Depleted uranium and human health 2.484
Copper-Induced Epigenetic Changes Shape the Clinical Phenotype in Wilson's Disease 2.460
A new tripodal-3-hydroxy-4-pyridinone for iron and aluminium sequestration: synthesis, complexation and in vivo studies 2.459
A new tripodal kojic acid derivative for iron sequestration: Synthesis, protonation, complex formation studies with Fe3+, Al3+, Cu2+ and Zn2+, and in vivo bioassays 2.424
Kojic acid derivatives as powerful chelators for iron(III) and aluminium(III) 2.319
Gold nanoparticles: A new golden Era in oncology? 2.290
Metal self-assembly mimosine peptides with enhanced antimicrobial activity: towards a new generation of multitasking chelating agentsts 2.276
Chelating principles in Menkes and Wilson diseases: Choosing the right compounds in the right combinations at the right time 2.250
Iron(III) and aluminum(III) complexes with hydroxypyrone ligands aimed to design kojic acid derivatives with new perspectives 2.245
A review on coordination properties of thiol-containing chelating agents towards mercury, cadmium, and lead 2.244
New insights into the protogenic and spectroscopic properties of commercial tannic acid: the role of gallic acid impurities 2.238
Do anti-diabetic drugs act as copper ligands? 2.224
Free fluoride determination in honey by ion-specific electrode potentiometry: method assessment, validation and application to real unifloral samples 2.202
Toxicity of nanoparticles: etiology and mechanisms 2.162
New strong extrafunctionalizable tris(3,4-HP) and bis(3,4-HP) metal sequestering agents: synthesis, solution and in vivo metal chelation 2.128
Arsenic toxicity: Molecular targets and therapeutic agents 2.094
Equilibrium studies of new bis-hydroxypyrone derivatives with Fe3+, Al3+, Cu2+ and Zn2+ 2.083
Tungsten or wolfram: Friend or foe? 2.060
Zinc(II) and copper(II) complexes with hydroxypyrone iron chelators 2.049
Complex formation equilibria of polyamine ligands with copper(II) and zinc(II) 2.040
Chelation therapy for metal intoxication. Comments from a thermodynamic view point 1.984
Fluoroquinolones: A micro-species equilibrium in the protonation of amphoteric compounds 1.975
Editorial: Applications of Medicinal Bioinorganic Chemistry 1.962
The meaning of aluminium exposure on human health and aluminium-related diseases 1.948
Kill or cure: Misuse of chelation therapy for human diseases 1.935
A new hydroxypyrone powerful chelator. From synthesis to AlIII, FeIII, CuII and ZnII complex formation equilibria, and structural characterization 1.920
A portable, disposable, and low-cost optode for sulphide and thiol detection 1.906
Substituent effects on ionization constants as a predictive tool of coordinating ability 1.902
Silver coordination compounds: A new horizon in medicine 1.890
Inexpensive Alizarin Red S-based optical device for the simultaneous detection of Fe(III) and Al(III) 1.860
Alarming use of chelation therapy 1.859
Iron III and aluminium III complexes with substituted salicyl-aldehydes and salicylic acids 1.847
Oxovanadium(IV) coordination compounds with kojic acid derivatives in aqueous solution 1.841
Chemical features of in use and in progress chelators for iron overload 1.841
Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one, with Al(III), Cu(II) and Zn(II) ions 1.830
Comparison of selectivity of a family of chelating agents for trivalent (Al3+, Fe3+) and bivalent (Cu2+, Zn2+) metal ions 1.822
Biomonitoring of toxic element exposure by ICP-AES and ICP-MS analysis 1.818
(5-Hydroxy-4-oxo-4H-pyran-2-yl)methyl3-({[(5-hydroxy-4-oxo-4H-pyran-2-yl)methoxy] carbonyl}amino) propanoate. Synthesis and its complex formation study 1.809
Noble metals in medicine: Latest advances 1.802
State of art in chelating agents for the clinical treatment of metal poisoning 1.802
An NMR study on the 6,6'-(2-(diethylamino)ethylazanediyl)bis(methylene)bis(5-hydroxy-2-hydroxymethyl-4H-pyran-4-one) interaction with Al(III) and Zn(II) ions 1.790
Hydroxypyrones, an intriguing family of chelating agents for Fe(III) and Al(III) 1.781
Medical uses of silver: history, myths and scientific evidence 1.781
5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one molecule as an intriguing tool in coordination and enzymatic studies 1.778
A speciation study on the perturbing effects of iron chelators on the homeostasis of essential metal ions 1.751
Unusual PLS application for Pd(ii) sensing in extremely acidic solutions 1.738
A family of hydroxypyrone ligands designed and synthesized for iron chelators 1.720
Chelating agents as therapeutic compounds - Basic principles 1.718
Sorption of chrysoidine by row cork and cork entrapped in calcium alginate beads 1.698
The Role of Magnesium in Pregnancy and in Fetal Programming of Adult Diseases 1.696
null 1.693
Uneven hepatic iron and phosphorus distribution in b-thalassemia 1.669
Losartan: a low water soluble oral drug with Cu(II) and Zn(II) coordination properties 1.648
Trace elements and the carotid plaque: the GOOD (Mg, Zn, Se), the UGLY (Fe, Cu), and the BAD (P, Ca)? 1.636
Uneven hepatic copper distribution in Wilson's disease 1.631
Competition between Cd(II) and other divalent transition metal ions during complex formation with amino acids, peptides, and chelating agents 1.619
Synthesis and Mass Spectrometry Analysis of Mimosine-Containing Peptides 1.595
Chelating agents for human diseases related to aluminium overload 1.567
Uneven cardiac iron distribution in beta-thalassemia 1.531
Iron and other metals in the pathogenesis of Parkinson's disease: Toxic effects and possible detoxification 1.529
Biomass against emerging pollution in wastewatee 1.504
Medicinal bio-inorganic chemistry: papers from the Third International Summer School of Bioinorganic Medicinal Chemistry, Cagliari, Italy 1.437
Optimization of a newly established gas-chromatographic method for determining lactose and galactose traces: Application to Pecorino Romano cheese 1.418
Toxicity of nanoparticles 1.397
Chelating agents for metal intoxication 1.362
The Potential Clinical Properties of Magnesium 1.329
Development of a sensor for trivalent iron: AHP fixed on mesoporous silica 1.326
Copper(II) and Nickel(II) uptake from aqueous solutions by cork wastes: a NMR and potentiometric study 1.319
Biomass against emerging pollution in wastewater: Ability of cork for the removal of ofloxacin from aqueous solutions at different pH 1.317
Deferoxamine-paper for iron(III) and vanadium(V) sensing 1.258
Metal ion toxicity 1.247
Iron chelating agents for iron overload diseases 1.244
Molecular recognition between adenine or 2,6-diaminopurine and copper(II) chelates with N,O2,S-tripodal tetradentate chelators having thioether or disulfide donor groups. 1.244
Analytical determination of total acidity in some Sardinian wines: evaluation of the contribute of different acids 1.243
Warns against unapproved ‘chelation therapy’ 1.220
Substituent effects on ionisation and 13C NMR properties of some monosubstituted phenols. A potentiometric, spectrophotometric and 13C NMR study 1.191
null 1.188
Thermodynamic Study of Oxidovanadium(IV) with Kojic Acid Derivatives: A Multi-Technique Approach 1.182
Medical therapy of patients contaminated with radioactive cesium or iodine 1.178
Metal ions in the pathogenesis of Alzheimer’s disease: an open field 1.176
Complex formation equilibria of Cu(II) and Zn(II) with triethylenetetramine and its mono- and di-acetyl metabolites 1.133
The aging kidney—as influenced by heavy metal exposure and selenium supplementation 1.131
Acidity and Structure of Fluoroquinolone Antibacterials 1.093
N,N '-Ethylenediaminobis(benzylphosphonic acids) as a potent class of chelators for metal ions 1.078
Totale 198.102
Categoria #
all - tutte 373.683
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 373.683


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20228.096 0 0 0 0 1.077 949 652 479 891 1.213 1.478 1.357
2022/202317.894 1.410 1.911 2.066 1.412 1.487 2.109 997 2.372 1.204 920 1.158 848
2023/202419.038 1.041 839 846 1.302 2.034 3.370 2.863 1.276 726 1.437 1.687 1.617
2024/202541.563 10.259 11.022 4.737 3.838 2.235 2.611 3.586 261 510 1.530 404 570
2025/202614.105 754 497 1.452 896 657 949 2.547 1.029 3.135 1.158 703 328
2026/20273.242 179 587 1.054 1.203 219 0 0 0 0 0 0 0
Totale 274.574